APA (7th ed.) Citation

S, Q., D, X., Y, X., H, Q., & P, L. (2026). Disease severity modifies the ceftazidime-avibactam exposure-response relationship in critically ill patients: A retrospective study. Frontiers in pharmacology, 17, 1833093. https://doi.org/10.3389/fphar.2026.1833093

Chicago Style (17th ed.) Citation

S, Qian, Xu D, Xu Y, Qi H, and Liang P. "Disease Severity Modifies the Ceftazidime-avibactam Exposure-response Relationship in Critically Ill Patients: A Retrospective Study." Frontiers in Pharmacology 17 (2026): 1833093. https://doi.org/10.3389/fphar.2026.1833093.

MLA (9th ed.) Citation

S, Qian, et al. "Disease Severity Modifies the Ceftazidime-avibactam Exposure-response Relationship in Critically Ill Patients: A Retrospective Study." Frontiers in Pharmacology, vol. 17, 2026, p. 1833093, https://doi.org/10.3389/fphar.2026.1833093.